- Home
- QLGN vs BDRX Comparison
QLGN vs BDRX Comparison
Compare QLGN & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- BDRX
- Stock Information
- Founded
- QLGN 1996
- BDRX 2000
- Country
- QLGN United States
- BDRX United Kingdom
- Employees
- QLGN N/A
- BDRX N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- QLGN Health Care
- BDRX Health Care
- Exchange
- QLGN Nasdaq
- BDRX Nasdaq
- Market Cap
- QLGN 2.4M
- BDRX 2.4M
- IPO Year
- QLGN N/A
- BDRX N/A
- Fundamental
- Price
- QLGN $3.32
- BDRX $1.43
- Analyst Decision
- QLGN
- BDRX
- Analyst Count
- QLGN 0
- BDRX 0
- Target Price
- QLGN N/A
- BDRX N/A
- AVG Volume (30 Days)
- QLGN 111.5K
- BDRX 3.5M
- Earning Date
- QLGN 04-15-2025
- BDRX 04-21-2025
- Dividend Yield
- QLGN N/A
- BDRX N/A
- EPS Growth
- QLGN N/A
- BDRX N/A
- EPS
- QLGN N/A
- BDRX N/A
- Revenue
- QLGN N/A
- BDRX $104,895.00
- Revenue This Year
- QLGN N/A
- BDRX N/A
- Revenue Next Year
- QLGN N/A
- BDRX N/A
- P/E Ratio
- QLGN N/A
- BDRX N/A
- Revenue Growth
- QLGN N/A
- BDRX N/A
- 52 Week Low
- QLGN $2.96
- BDRX $1.14
- 52 Week High
- QLGN $29.45
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- QLGN 44.88
- BDRX 33.58
- Support Level
- QLGN $3.06
- BDRX $1.15
- Resistance Level
- QLGN $3.78
- BDRX $1.68
- Average True Range (ATR)
- QLGN 0.28
- BDRX 0.23
- MACD
- QLGN 0.03
- BDRX 0.03
- Stochastic Oscillator
- QLGN 19.80
- BDRX 17.23
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.